Hospital
ST. Luke's Hospital of Duluth
ST. Luke's Hospital of Duluth was paid $26.63M by Medicaid between Jan 2018 and Dec 2024, across 208 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 38% of everything it billed.
33Billing provider infoST. LUKE'S HOSPITAL OF DULUTH
DULUTH, MN 55805
DULUTH, MN 55805
33aNPI1801835970assigned 06/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.63M
24GClaims484,578
24DCodes billed208
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Minnesota
Rank by total paid#10 of 36
Median peer was paid$11.46M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BECKER, KATHERINE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 85,290 | $1.73M | |
| 2019 | 79,983 | $4.54M | |
| 2020 | 55,570 | $3.44M | |
| 2021 | 76,987 | $4.45M | |
| 2022 | 71,182 | $4.62M | |
| 2023 | 70,536 | $4.80M | |
| 2024incomplete | 45,030 | $3.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 38% | 147,734 | 129,903 | $10.24M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 18,632 | 17,138 | $4.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 15,426 | 14,423 | $2.71M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 6.8% | 8,447 | 4,446 | $1.82M |
| 36415 | Collection of venous blood by venipuncture | 5.1% | 58,452 | 49,403 | $1.36M |
| 90870 | 2.7% | 3,035 | 1,167 | $711K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 34,026 | 28,826 | $529K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.8% | 2,663 | 2,333 | $489K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.7% | 19,230 | 16,977 | $441K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 4,571 | 4,320 | $358K |
| 80053 | Comprehensive metabolic panel | 1.2% | 13,978 | 11,493 | $323K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,469 | 3,225 | $264K |
196 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,949 | $213K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 4,096 | $181K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,337 | $120K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 254 | $95K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,013 | $79K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,158 | $71K |
| 81001 | <1% | 3,747 | $70K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,445 | $68K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 979 | $67K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,725 | $66K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 687 | $57K |
| 90837 | Psychotherapy session, about an hour | <1% | 575 | $53K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 748 | $51K |
| 97161 | <1% | 1,341 | $50K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,789 | $49K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,601 | $49K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 890 | $47K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,865 | $46K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,774 | $45K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,228 | $44K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,083 | $44K |
| 92015 | Determination of refractive state | <1% | 2,175 | $43K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 72 | $43K |
| 80076 | <1% | 2,967 | $40K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,417 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,017 | $36K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 346 | $36K |
| 11045 | <1% | 123 | $35K | |
| 97597 | <1% | 537 | $35K | |
| 91300 | <1% | 2,255 | $34K | |
| 29581 | <1% | 137 | $33K | |
| 99223 | Prolong inpt eval add15 m | <1% | 249 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 560 | $30K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,809 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 214 | $30K |
| 80061 | Lipid panel | <1% | 3,100 | $29K |
| 71045 | Radiologic examination, chest; single view | <1% | 674 | $29K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,616 | $26K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 358 | $25K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 212 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,083 | $22K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 680 | $21K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,790 | $20K |
| 83735 | <1% | 2,950 | $18K | |
| 0002A | <1% | 1,254 | $18K | |
| 0001A | <1% | 1,296 | $18K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 2,368 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,899 | $17K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 908 | $17K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 238 | $16K |
| 82565 | <1% | 593 | $16K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,184 | $16K |
| 80306 | <1% | 1,448 | $16K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,306 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 482 | $15K |
| 83690 | <1% | 1,579 | $14K | |
| 85027 | <1% | 1,769 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,229 | $13K |
| 86140 | <1% | 2,818 | $13K | |
| 81003 | <1% | 1,255 | $12K | |
| J3490 | Unclassified drugs | <1% | 1,338 | $12K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 142 | $11K |
| 86780 | <1% | 1,257 | $11K | |
| 82948 | <1% | 984 | $11K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 18 | $10K |
| 85610 | <1% | 2,079 | $10K | |
| 84484 | <1% | 745 | $10K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 398 | $10K |
| 69210 | <1% | 306 | $9K | |
| 0003A | <1% | 558 | $9K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 557 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 204 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 42 | $8K |
| 86481 | <1% | 86 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 153 | $7K |
| 64615 | <1% | 57 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,968 | $7K |
| 93296 | <1% | 214 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 61 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,644 | $6K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 84 | $6K |
| 83615 | <1% | 651 | $5K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 257 | $5K |
| 91307 | <1% | 307 | $5K | |
| 20553 | <1% | 41 | $5K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 158 | $5K |
| 86850 | <1% | 1,344 | $4K | |
| 87340 | <1% | 510 | $4K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 122 | $4K |
| 82607 | <1% | 387 | $4K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 76 | $4K |
| 0013A | <1% | 222 | $4K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 41 | $4K |
| 87077 | <1% | 716 | $4K | |
| 87081 | <1% | 352 | $4K | |
| 84439 | <1% | 631 | $4K | |
| 90662 | <1% | 253 | $4K | |
| 87070 | <1% | 820 | $4K | |
| 86803 | <1% | 325 | $4K | |
| 87522 | Neg quan hep c or qual rna | <1% | 72 | $4K |
| 82728 | <1% | 446 | $3K | |
| 87653 | <1% | 98 | $3K | |
| 92551 | <1% | 52 | $3K | |
| G0378 | Hospital observation service, per hour | <1% | 240 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 318 | $3K |
| 0054A | <1% | 162 | $3K | |
| 87186 | <1% | 543 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 229 | $3K |
| 90688 | <1% | 228 | $3K | |
| 84145 | <1% | 98 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 56 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,424 | $3K |
| 83550 | <1% | 620 | $3K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 18 | $3K |
| 0124A | <1% | 105 | $3K | |
| 80069 | <1% | 151 | $3K | |
| 83655 | <1% | 248 | $3K | |
| 0072A | <1% | 139 | $3K | |
| 83540 | <1% | 760 | $3K | |
| 0071A | <1% | 137 | $2K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 27 | $2K |
| 91306 | <1% | 179 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 15 | $2K |
| 95886 | <1% | 13 | $2K | |
| 92557 | <1% | 37 | $2K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 50 | $2K |
| 91305 | <1% | 151 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 865 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 548 | $2K |
| 84100 | <1% | 210 | $2K | |
| 86762 | <1% | 119 | $2K | |
| 86900 | <1% | 758 | $2K | |
| 90686 | <1% | 671 | $2K | |
| 86901 | <1% | 816 | $1K | |
| 92567 | <1% | 193 | $1K | |
| 85652 | <1% | 613 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 74 | $1K |
| 84550 | <1% | 152 | $1K | |
| 81025 | <1% | 93 | $1K | |
| 97162 | <1% | 40 | $1K | |
| 73630 | <1% | 71 | $985.37 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,894 | $872.32 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,390 | $824.96 |
| 0031A | <1% | 76 | $813.06 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $764.62 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 20 | $752.13 |
| 83605 | <1% | 136 | $735.85 | |
| 91301 | <1% | 47 | $688.16 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $681.42 |
| 82077 | <1% | 14 | $654.86 | |
| 91322 | <1% | 12 | $620.97 | |
| 84460 | <1% | 159 | $619.62 | |
| 82043 | <1% | 244 | $574.04 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 12 | $561.06 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 117 | $523.99 |
| 91303 | <1% | 74 | $516.12 | |
| 86618 | <1% | 32 | $456.19 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 26 | $445.80 |
| 90682 | <1% | 27 | $429.91 | |
| 90480 | <1% | 24 | $403.13 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | $358.70 |
| 84481 | <1% | 31 | $349.68 | |
| 0012A | <1% | 41 | $314.80 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $305.43 |
| A9270 | Non-covered item or service | <1% | 5,949 | $281.98 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 607 | $278.62 |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 27 | $275.13 |
| 85018 | <1% | 204 | $264.30 | |
| 0011A | <1% | 20 | $257.44 | |
| 91311 | <1% | 30 | $254.76 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 12 | $205.24 |
| 0052A | <1% | 12 | $201.84 | |
| 84450 | <1% | 24 | $191.90 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 12 | $147.50 |
| 99173 | <1% | 37 | $145.53 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 53 | $133.68 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 196 | $118.41 |
| 0074A | <1% | 12 | $112.32 | |
| 94726 | <1% | 14 | $104.19 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 23 | $98.67 |
| 92134 | <1% | 497 | $92.03 | |
| 99490 | Ccm add 20min | <1% | 64 | $72.67 |
| 0111A | <1% | 14 | $66.96 | |
| 94729 | <1% | 13 | $64.38 | |
| 87205 | <1% | 14 | $41.24 | |
| 84156 | <1% | 15 | $40.73 | |
| 36416 | <1% | 32 | $19.72 | |
| 88342 | <1% | 17 | $11.78 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 15 | $4.04 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 21 | $0.00 |
| 90656 | 0% | 15 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 61 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 108 | $0.00 |
| 67028 | Intravitreal injection of a pharmacologic agent | 0% | 50 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 76 | $0.00 |
| 90670 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBECKER, KATHERINE (VP COMPLIANCE)
| Provider | Location | Paid |
|---|---|---|
| ST. Luke's Hospital of Duluth | Duluth, MN | $2.90M |
| ST. Luke's Hospital of Duluth | Duluth, MN | $1.92M |
| ST. Luke's Hospital of Duluth | Duluth, MN | $1.62M |
| ST. Luke's Hospital of Duluth | Duluth, MN | $1.00M |
| ST. Luke's Hospital of Duluth | Hermantown, MN | $841K |
| ST. Luke's Hospital of Duluth | Hibbing, MN | $801K |
| ST. Luke's Hospital of Duluth | Ashland, WI | $504K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $497K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $441K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $273K |
| ST. Luke's Hospital of Duluth | Virginia, MN | $251K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $250K |
| ST. Luke's Hospital of Duluth | Superior, WI | $152K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $119K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $115K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $114K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $92K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $86K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $81K |
| ST. Luke's Hospital of Duluth | Duluth, MN | $80K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.